The aim of this work was to investigate and quantitatively evaluate the effect of presence of alcohol on in vitro release of ionizing and non-ionizing drug from hydrophilic, lipophilic and hydrophilic-lipophilic matrix tablets. The Food and Drug Administration (FDA) recommends in vitro dissolution testing of extended release formulations in ethanolic media up to 40% because of possible alcohol-induced dose dumping effect. This study is focused on comparison of the dissolution behavior of matrix tablets (based on hypromellose and/or glyceryl behenate as retarding agent) of the same composition containing different type of drug - ionizing tramadol hydrochloride (TH) and non-ionizing pentoxifylline (PTX). The dissolution tests were performed in acidic medium (pH 1.2) and in alcoholic medim (20%, 40% of ethanol) and the changes of tablets were observed also photographically. It was found that the alcohol resistence of the hydrophilic-lipophilic formulations with TH and the hydrophilic-lipophilic formulations with PTX containing a higher amount of hypromellose does not reflect the alcohol resistence of the formulations with pure hypromellose or glyceryl behenate. Both hydrophilic-lipophilic formulation with TH and more lipophilic formulation with PTX show significant alcohol dose dumping effect.

Department of Analytical Chemistry Faculty of Chemical Technology University of Pardubice Studentská 95 532 10 Pardubice Czech Republic

Department of Pharmaceutical Technology Charles University Faculty of Pharmacy in Hradec Králové Akademika Heyrovského 1203 500 05 Hradec Králové Czech Republic

Department of Physical Chemistry Faculty of Chemical Technology University of Pardubice Studentská 95 532 10 Pardubice Czech Republic

SPS Pharma Services 3 Rue Châteaubriand 45071 Orléans France

Zobrazit více v PubMed

Aburahma M.H., Baldr-Eldin S.M. Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals. Expert Opin. Drug Deliv. 2014;11(12):1865–1883. PubMed

Akerlof G. Dielectric constants of some organic solvent-water mixtures at various temperatures. J. Am. Chem. Soc. 1932;54:4125–4139.

Bettini R., Colombo P., Massimo G., Gatellani P.L., Vitali T. Swelling and drug release in hydrogel matrices: polymer viscosity and matrix porosity effects. Eur. J. Pharm. Sci. 1994;2:213–219.

Colombo P., Bettini R., Santi P., DeAscentiis A., Peppas N.A. Analysis of the swelling annd release mechanisms from drug delivery systems with emphasis on drug solubility and water transport. J. Control. Release. 1996;39:231–237.

Costa P., Sousa Lobo J.M. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 2001;13:123–133. PubMed

Dow Chemical Company: METHOCELL Cellulose Ethers. Technical Handbook. http://msdssearch.dow.com/PublishedLiteratureDOWCOM/dh_096d/0901b8038096d9ff.pdf?filepath=/pdfs/noreg/192-01062.pdf&fromPage=GetDoc.

Driver S. Glyceryl Behenate. In: Sheskey P.J., Cook W.G., Cable C.G., editors. Handbook of Pharmaceutical Excipients. 8th ed. Pharmaceutical Press; London: 2017. pp. 405–409.

DrugBank1: https://www.drugbank.ca/salts/DBSALT000181.

DrugBank2: https://www.drugbank.ca/drugs/DB00806.

European Pharmacopoeia (Ph. Eur.), 9th Edition, Council of Europe, Strasbourg, 2017.

FDA, 2005a, FDA asks Purdue Pharma to withdraw Palladone. FDA Consum., 39 (5). PubMed

FDA, 2005b. Hydromorphone hydrochloride extended release capsules (marketed as Palladone™). FDA alert 07/2005.

Franke A., Teyssen S., Harder H., Singer M.V. Effect of ethanol and some ethanolic beverages on gastric emptying in humans. Scand. J. Gastroenterol. 2004;39(7):638–644. PubMed

Gattefossé 1 : Compritol ® 888 ATO A smart solution to sustain drug release. https://www.gattefosse.com/back/files/Gattefosse%20Compritol%20888%20ATO%20A%20smart%20solution%20to%20sustain%20drug%20release.pdf.

Gattefossé 2. Developing sustained release tablets with Compritol® 888 ATO. Formulation Guidelines, Version 2, 2010.

Jedinger N., Khinast J., Roblegg E. The design of controlled-release formulations resistant to alcohol-induced dose dumping – a review. Eur. J. Pharm. Biopharm. 2014;87:217–226. PubMed

Jedinger N., Schrank S., Mohr S., Feichtinger A., Khinast J., Roblegg E. Alcohol dose dumping: the influence of ethanol on hot-melt extruded pellets comprising solid lipids. Eur. J. Pharm. Biopharm. 2015;92:83–95. PubMed

Keen J.M., Foley C.J., Hughey J.R., Bennett R.C., Jannin V., Rosiaux Y., Marchaud D., McGinity J.W. Continuous twin screw melt granulation of glyceryl behenate: development of controlled release tramadol hydrochloride tablets for improved safety. Int. J. Pharm. 2015;487:72–80. PubMed

Khan K.A. The concept of dissolution efficiency. J. Pharm. Pharmacol. 1975;27:48–49. PubMed

Komersová A., Lochař V., Myslíková K., Mužíková J., Bartoš M. Formulation and dissolution kinetics study of hydrophilic matrix tablets with tramadol hydrochloride and different co-processed dry binders. Eur. J. Pharm. Sci. 2016;95:36–45. PubMed

Levina M., Vuong H., Rajabi-Siahboomi A.R. The influence of hydro-alcoholic media on hypromellose matrix systems. Drug Dev. Ind. Pharm. 2007;33:1125–1134. PubMed

Li C.L., Martini L.G., Ford J.L., Roberts M. The use of hypromellose in oral drug delivery. J. Pharm. Pharmacol. 2005;57(5):533–546. PubMed

Li F.Q., Hu J.H., Deng J.X., Su H., Xu S., Liu J.Y. In vitro controlled release of sodium ferulate from Compritol 888ATO based matrix tablets. Int. J. Pharm. 2006;324:152–157. PubMed

Missaghi S., Fegely K.A., Rajabi-Siahboomi A.R. Investigation of the effects of hydroalcoholic solutions on textural and rheological properties of various controlled release grades of hypromellose. AAPS PharmSciTech. 2009;10:77–80. PubMed PMC

Rodriguez C.F., Bruneua N., Barra J., Alfonso D., Doelker E. Hydrophilic cellulose derivatives as drug delivery carriers: Influence of substitution type on the properties of compressed matrix tablets. In: Wise D.L., editor. Handbook of Pharmaceutical Controlled Release Technology. Marcel Dekker Inc; New York: 2000. pp. 1–30.

Walden M., Nicholls F.A., Smith K.J., Tucker G.T. The effect of ethanol on the release of opioids from oral prolonged-release preparations. Drug Dev. Ind. Pharm. 2007;33(10):1101–1111. PubMed PMC

Matrix Tablets Based on Chitosan-Carrageenan Polyelectrolyte Complex: Unique Matrices for Drug Targeting in the Intestine

3D-Printed Coating of Extended-Release Matrix Tablets: Effective Tool for Prevention of Alcohol-Induced Dose Dumping Effect